Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 1:11:151.
doi: 10.3389/fnmol.2018.00151. eCollection 2018.

ADNP, a Microtubule Interacting Protein, Provides Neuroprotection Through End Binding Proteins and Tau: An Amplifier Effect

Affiliations

ADNP, a Microtubule Interacting Protein, Provides Neuroprotection Through End Binding Proteins and Tau: An Amplifier Effect

Illana Gozes et al. Front Mol Neurosci. .
No abstract available

Keywords: ADNP; microtubule end binding proteins; microtubule-associated proteins; microtubules; tau.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The illustration shows the mechanism of NAP/ADNP neuroprotection against tauopathy in the disease state. In the healthy state, ADNP enhances axonal transport and synaptic plasticity. ADNP has two adjacent SIP motifs, one within the NAP sequence and one upstream (Bassan et al., ; Zamostiano et al., 2001). A NAP—related peptide SKIP (encompassing the SxIP motif), enhances axonal transport in Adnp haploinsufficient mice, probably through the same mechanism (Amram et al., 2016). In tissue culture cells, NAP also enhances dendritic spine formation (synaptic plasticity) through an EB3-depedent mechanism (Oz et al., 2014).

Similar articles

Cited by

References

    1. Amram N., Hacohen-Kleiman G., Sragovich S., Malishkevich A., Katz J., Touloumi O., et al. . (2016). Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory. Mol. Psychiatry 21, 1467–1476. 10.1038/mp.2015.208 - DOI - PubMed
    1. Bassan M., Zamostiano R., Davidson A., Pinhasov A., Giladi E., Perl O., et al. . (1999). Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J. Neurochem. 72, 1283–1293. 10.1046/j.1471-4159.1999.0721283.x - DOI - PubMed
    1. Brenneman D. E., Gozes I. (1996). A femtomolar-acting neuroprotective peptide. J. Clin. Invest. 97, 2299–2307. 10.1172/JCI118672 - DOI - PMC - PubMed
    1. Brenneman D. E., Hauser J., Neale E., Rubinraut S., Fridkin M., Davidson A., et al. . (1998). Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides. J. Pharmacol. Exp. Ther. 285, 619–627. - PubMed
    1. Chen S. Y., Charness M. E., Wilkemeyer M. F., Sulik K. K. (2005). Peptide-mediated protection from ethanol-induced neural tube defects. Dev. Neurosci. 27, 13–19. 10.1159/000084528 - DOI - PubMed

LinkOut - more resources